lobbying_filings_raw: 0d03fdf2-7eae-4e56-99c7-952aa5b720d9
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0d03fdf2-7eae-4e56-99c7-952aa5b720d9 | Q4 | 30291 | OREGON HEALTH & SCIENCE UNIVERSITY | 135800 | OREGON HEALTH & SCIENCE UNIVERSITY | 2017 | fourth_quarter | 2018-01-18T13:30:17.057000-05:00 | 80000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/0d03fdf2-7eae-4e56-99c7-952aa5b720d9/", "filing_uuid": "0d03fdf2-7eae-4e56-99c7-952aa5b720d9", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2017, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/0d03fdf2-7eae-4e56-99c7-952aa5b720d9/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "80000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Abigail Tibbs, Associate Vice President, OHSU Government Relations", "dt_posted": "2018-01-18T13:30:17.057000-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "3181 S.W. SAM JACKSON PARK ROAD", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "PORTLAND", "registrant_state": "OR", "registrant_zip": "97239", "registrant": {"id": 30291, "url": "https://lda.senate.gov/api/v1/registrants/30291/", "house_registrant_id": 31946, "name": "OREGON HEALTH & SCIENCE UNIVERSITY", "description": "Academic Health Center", "address_1": "3181 S.W. SAM JACKSON PARK ROAD", "address_2": null, "address_3": null, "address_4": null, "city": "PORTLAND", "state": "OR", "state_display": "Oregon", "zip": "97239", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "LINDSEY CAPPS", "contact_telephone": "+1 971-429-1723", "dt_updated": "2026-01-16T12:19:53.637706-05:00"}, "client": {"id": 135800, "url": "https://lda.senate.gov/api/v1/clients/135800/", "client_id": 12, "name": "OREGON HEALTH & SCIENCE UNIVERSITY", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "OR", "state_display": "Oregon", "country": "US", "country_display": "United States of America", "ppb_state": "OR", "ppb_state_display": "Oregon", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-13"}, "lobbying_activities": [{"general_issue_code": "FIR", "general_issue_code_display": "Firearms/Guns/Ammunition", "description": "FY 2017 Funding for Centers for Disease Control research on gun violence.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "ANI", "general_issue_code_display": "Animals", "description": "Animal Welfare Act and Horse Protection Act; issues related to the use of animals in biomedical research.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "Protecting innovators from frivolous patent lawsuits: \"Innovation Act\" (HR 9).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "340b Drug Discount Program for safety net hospitals and Health Resources and Services Administration proposed omnibus guidance.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Impact of Budget Control Act of 2011's Sequestration on medical research; use of animals in biomedical research; moving medical research from bench to bedside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tied with additional review in post-market: \"21st Century Cures Act\" (H.R. 34); FDA regulation of mitochondrial replacement therapy Sections 736 in \"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017\" (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research program; FDA regulation of laboratory developed test.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Maintaining the current charitable tax deduction; HR 1, Tax Cuts and Jobs Act (PL 115-97; issues related to tax reform.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Adequacy of health care workforce associated with expansion of health care coverage; Affordable Care Act (P.L. 111-148) repeal and Market Stabilization Proposed Rule, H.R. 1628 American Health Care Act of 2017/Better Care Reconciliation Act of 2017; Re authorization of the Children's Health Insurance Program (CHIP); issues related to health care coverage.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "VET", "general_issue_code_display": "Veterans", "description": "Access to care for veterans and physician workforce issues.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Preventing cuts to Medicare Graduate Medical Education payments; preventing cuts to Disproportionate Share Hospital Payments: \"The Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015\" (H.R. 3288); Preventing reductions to Hospital Inpatient and Outpatient PPS Payments: \"The Medicare Crosswalk Hospital Code Development Act of 2015\" (H.R. 3291), Medicare payments for Off-Campus Hospital outpatient departments; implementation of Section 603 \"Bipartisan Budget Act of 2015)\" (H.R. 1314), \"Helping Hospitals Improve Patient Care Act of 2016\" (H.R. 5273) 21st Century Cures Act (H.R. 34); Additional Medicare support for Medicare Graduate Medical Education; Medicare payment for short hospital stays; Preventing reductions to the Medicaid program including the provider tax; Improvements to the Medicaid program for medically complex children.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "FDA regulation of mitochondrial replacement therapy Sections 736 in \"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017\" (HR 5054/ S.2956); FY2017 funding for Zika: \"Zika Response Appropriations Act, 2016\" (HR5243), Division B in \"Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017\" (HR 2577). FY2017 and FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; HR 244, Consolidated Appropriations Act 2017 (P.L. 115-31); health and science related funding issues. HR 3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; HJ Res. 123, Making further continuing appropriations for fiscal year 2018, and for other purposes (PL 115-90); HR 1370, Further Additional Continuing Appropriations Act, 2018 (PL 115-96); health and science related funding issues.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 65748, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "TIBBS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | OR | US | 31946 | OR | OR | US | US | 0 | 0 | 2246962 | normalized_name_state | 0.9 |